Abstract
Glucose is a primary energy source in living cells. The discovery in 1960s that a sodium gradient powers the active uptake of glucose in the intestine1 heralded the concept of a secondary active transporter that can catalyse the movement of a substrate against an electrochemical gradient by harnessing energy from another coupled substrate. Subsequently, coupled Na+/glucose transport was found to be mediated by sodium–glucose cotransporters2,3 (SGLTs). SGLTs are responsible for active glucose and galactose absorption in the intestine and for glucose reabsorption in the kidney4, and are targeted by multiple drugs to treat diabetes5. Several members within the SGLT family transport key metabolites other than glucose2. Here we report cryo-electron microscopy structures of the prototypic human SGLT1 and a related monocarboxylate transporter SMCT1 from the same family. The structures, together with molecular dynamics simulations and functional studies, define the architecture of SGLTs, uncover the mechanism of substrate binding and selectivity, and shed light on water permeability of SGLT1. These results provide insights into the multifaceted functions of SGLTs.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kleinzeller, A. & Kotyk, A. Membrane Transport and Metabolism (Publishing House of the Czechoslovak Academy of Sciences, 1961).
Wright, E. M., Loo, D. D. F. & Hirayama, B. A. Biology of human sodium glucose transporters. Physiol. Rev. 91, 733–794 (2011).
Hopfer, U., Nelson, K. & Isselbacher, K. J. Specific glucose transport in isolated brush border membranes from rat small-intestine. J. Biol. Chem. 248, 25–32 (1973).
Wright, E. M. Renal Na+–glucose cotransporters. Am. J. Physiol. Renal Physiol. 280, F10–F18 (2001).
Hsia, D. S., Grove, O. & Cefalu, W. T. An update on sodium-glucose co-transporter-2 inhibitors for the treatment of diabetes mellitus. Curr. Opin. Endocrinol. Diabetes Obes. 24, 73–79 (2017).
Hummel, C. S. et al. Glucose transport by human renal Na+/d-glucose cotransporters SGLT1 and SGLT2. Am. J. Physiol. Cell Physiol. 300, C14–C21 (2011).
Turk, E., Zabel, B., Mundlos, S., Dyer, J. & Wright, E. M. Glucose galactose malabsorption caused by a defect in the Na+/glucose cotransporter. Nature 350, 354–356 (1991).
Hirschhorn, N. et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N. Engl. J. Med. 279, 176–181 (1968).
Zeuthen, T., Gorraitz, E., Her, K., Wright, E. M. & Loo, D. D. F. Structural and functional significance of water permeation through cotransporters. Proc. Natl Acad. Sci. USA 113, E6887–E6894 (2016).
Loo, D. D. et al. Passive water and ion transport by cotransporters. J. Physiol. 518, 195–202 (1999).
Faham, S. et al. The crystal structure of a sodium galactose transporter reveals mechanistic insights into Na+/sugar symport. Science 321, 810–814 (2008).
Wahlgren, W. Y. et al. Substrate-bound outward-open structure of a Na+-coupled sialic acid symporter reveals a new Na+ site. Nat. Commun. 9, 1753 (2018).
Leung, D. W., Turk, E., Kim, O. & Wright, E. M. Functional expression of the Vibrio parahaemolyticus Na+/galactose (vSGLT) cotransporter in Xenopus laevis oocytes. J. Membr. Biol. 187, 65–70 (2002).
Canul-Tec, J. C. et al. Structure and allosteric inhibition of excitatory amino acid transporter 1. Nature 544, 446–451 (2017).
Suzuki, T. et al. Apical localization of sodium-dependent glucose transporter SGLT1 is maintained by cholesterol and microtubules. Acta Histochem. Cytochem. 39, 155–161 (2006).
Ghezzi, C., Calmettes, G., Morand, P., Ribalet, B. & John, S. Real-time imaging of sodium glucose transporter (SGLT1) trafficking and activity in single cells. Physiol. Rep. 5, e13062 (2017).
Penmatsa, A., Wang, K. H. & Gouaux, E. X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503, 85–90 (2013).
Gagnon, D. G., Bissonnette, P. & Lapointe, J. Y. Identification of a disulfide bridge linking the fourth and the seventh extracellular loops of the Na+/glucose cotransporter. J. Gen. Physiol. 127, 145–158 (2006).
Wright, E. M. in Genetic Diseases of the Kidney (eds Lifton, R. P. et al.) 131–140 (2009).
Sala-Rabanal, M. et al. Bridging the gap between structure and kinetics of human SGLT1. Am. J. Physiol. Cell Physiol. 302, C1293–C1305 (2012).
Bisignano, P. et al. Inhibitor binding mode and allosteric regulation of Na+–glucose symporters. Nat. Commun. 9, 5245 (2018).
Gopal, E. et al. Expression of slc5a8 in kidney and its role in Na+-coupled transport of lactate. J. Biol. Chem. 279, 44522–44532 (2004).
Miyauchi, S., Gopal, E., Fei, Y. J. & Ganapathy, V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na+-coupled transporter for short-chain fatty acids. J. Biol. Chem. 279, 13293–13296 (2004).
Cui, D. & Morris, M. E. The drug of abuse γ-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab. Dispos. 37, 1404–1410 (2009).
Gopal, E. et al. Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. Pharm. Res. 24, 575–584 (2007).
Li, H. et al. SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers. Proc. Natl Acad. Sci. USA 100, 8412–8417 (2003).
Ganapathy, V. et al. Sodium-coupled monocarboxylate transporters in normal tissues and in cancer. AAPS J. 10, 193–199 (2008).
Diez-Sampedro, A., Lostao, M. P., Wright, E. M. & Hirayama, B. A. Glycoside binding and translocation in Na+-dependent glucose cotransporters: comparison of SGLT1 and SGLT3. J. Membr. Biol. 176, 111–117 (2000).
Choe, S., Rosenberg, J. M., Abramson, J., Wright, E. M. & Grabe, M. Water permeation through the sodium-dependent galactose cotransporter vSGLT. Biophys. J. 99, L56–L58 (2010).
Vandenberg, R. J., Handford, C. A., Campbell, E. M., Ryan, R. M. & Yool, A. J. Water and urea permeation pathways of the human excitatory amino acid transporter EAAT1. Biochem. J 439, 333–340 (2011).
Turk, E. et al. Molecular characterization of Vibrio parahaemolyticus vSGLT: a model for sodium-coupled sugar cotransporters. J. Biol. Chem. 275, 25711–25716 (2000).
Goehring, A. et al. Screening and large-scale expression of membrane proteins in mammalian cells for structural studies. Nat. Protoc. 9, 2574–2585 (2014).
Pardon, E. et al. A general protocol for the generation of nanobodies for structural biology. Nat. Protoc. 9, 674–693 (2014).
McMahon, C. et al. Yeast surface display platform for rapid discovery of conformationally selective nanobodies. Nat. Struct. Mol. Biol. 25, 289–296 (2018).
Hediger, M. A., Ikeda, T., Coady, M., Gundersen, C. B. & Wright, E. M. Expression of size-selected mRNA encoding the intestinal Na/glucose cotransporter in Xenopus laevis oocytes. Proc. Natl Acad. Sci. USA 84, 2634–2637 (1987).
Leung, D. W., Loo, D. D., Hirayama, B. A., Zeuthen, T. & Wright, E. M. Urea transport by cotransporters. J. Physiol. 528 251–257 (2000).
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005).
Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017).
Zhang, K. Gctf: real-time CTF determination and correction. J. Struct. Biol. 193, 1–12 (2016).
Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018).
Heymann, J. B. & Belnap, D. M. Bsoft: image processing and molecular modeling for electron microscopy. J. Struct. Biol. 157, 3–18 (2007).
Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296–W303 (2018).
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D 66, 486–501 (2010).
Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D 66, 213–221 (2010).
Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D 66, 12–21 (2010).
The PyMOL Molecular Graphics System v.2.0. (Schrödinger, 2017).
Pettersen, E. F. et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).
Laskowski, R. A. & Swindells, M. B. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778–2786 (2011).
Lomize, M. A., Lomize, A. L., Pogozheva, I. D. & Mosberg, H. I. OPM: orientations of proteins in membranes database. Bioinformatics 22, 623–625 (2006).
Jacobson, M. P., Friesner, R. A., Xiang, Z. & Honig, B. On the role of the crystal environment in determining protein side-chain conformations. J. Mol. Biol. 320, 597–608 (2002).
Betz, R. Dabble (v2.6.3). Zenodo https://zenodo.org/record/836914#.YZz6AWDP2M8 (2017).
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J. Phys. Chem. B 114, 7830–7843 (2010).
Guvench, O., Hatcher, E. R., Venable, R. M., Pastor, R. W. & Mackerell, A. D. CHARMM additive all-atom force field for glycosidic linkages between hexopyranoses. J. Chem. Theory Comput. 5, 2353–2370 (2009).
Case, D. A., et al. AMBER 2018 (Univ. California, San Francisco, 2018).
Hopkins, C. W., Le Grand, S., Walker, R. C. & Roitberg, A. E. Long-time-step molecular dynamics through hydrogen mass repartitioning. J. Chem. Theory Comput. 11, 1864–1874 (2015).
Jean-Paul Ryckaert, G. C., Herman, J. C. B. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327–341 (1977).
Roe, D. R. & Cheatham, T. E. III. PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data. J. Chem. Theory Comput. 9, 3084–3095 (2013).
William Humphrey, A. D., Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
Nguyen, C. N., Young, T. K. & Gilson, M. K. Grid inhomogeneous solvation theory: hydration structure and thermodynamics of the miniature receptor cucurbit[7]uril. J. Chem. Phys. 137, 044101 (2012).
Ramsey, S. et al. Solvation thermodynamic mapping of molecular surfaces in AmberTools: GIST. J. Comput. Chem. 37, 2029–2037 (2016).
Acknowledgements
This work was made possible by support from Stanford University and the Harold and Leila Y. Mathers Charitable Foundation to L.F. and G.S., a Dean’s Fellowship to L.H., a Stanford Bio-X seed grant to R.O.D. and G.S., the SNSF Early Postdoctoral Mobility fellowship P2ELP3_187989 and the EMBO Long-Term Fellowship ALTF 544-2019 to D.A. L.F. was an NIH Director’s New Innovator awardee. Cryo-EM data for this work was collected at the Stanford-SLAC cryo-EM facility. We thank members of the Feng and Skiniotis laboratories for helpful discussions, Dror laboratory members J. Paggi, S. Eismann, M. Dämgen and M. Vögele for assistance with molecular dynamics simulations and analysis, and E. Montabana for support with data collection.
Author information
Authors and Affiliations
Contributions
L.H. performed molecular biology, protein expression and purification, biochemistry and functional studies. Q.Q. prepared cryo-EM grids, collected and processed data, and reconstructed the maps of SGLT1con, SGLT1conHA and SMCT1. L.H. built the model with the input from Q.Q. D.A. performed and analysed molecular dynamics simulations and contributed to preparation of the figures and manuscript. M.J.R. assisted with model building. Y.X. performed biochemistry and protein engineering. O.P. prepared cryo-EM grids, collected and processed data, and reconstructed the map of SGLT1conHA. R.O.D. oversaw the molecular dynamics simulations and contributed to the manuscript preparation. L.H., Q.Q., G.S. and L.F. wrote the manuscript with the input from all co-authors. G.S. and L.F. supervised the project.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Peer review information Nature thanks David Drew, Bernard Thorens and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Sequence alignments of selected SSS transporters.
The sequences of selected SSS transporters were aligned using Clustal Omega (http://www.uniprot.org/) and adjusted manually. The secondary structural elements of SGLT1 are indicated above the sequence alignment. The mutations in SGLT1con are highlighted.
Extended Data Fig. 2 Sequence alignments of SMCT homologs.
The sequences of selected SMCT homologs were aligned using Clustal Omega (http://www.uniprot.org/) and adjusted manually. The secondary structural elements of SMCT1 are indicated above the sequence alignment.
Extended Data Fig. 3 Glucose uptake of SGLT1 mutants.
a, Uptake activities of SGLT1con and SGLT1conHA. SGLT1conHA is the same as SGLT1con, except that W660 and G661 of SGLT1con are reversed to H660 and A661. The uptake buffer contains different combinations of sodium (Na), choline (Ch), or phlorizin (Pz) as indicated. Uptake of αMDG is shown (mean ± SEM; n=4 biological replicates). b, Uptake activities of SGLT1 and SGLT1-WG mutant, in which H660 and A661 are substituted with W660 and G661 (mean ± SEM; n=4 biological replicates). c, Uptake activities of SGLT1 with mutations in the cholesterol-binding site (mean ± SEM; n=4 biological replicates). d, Thermostability of SGLT1con (left) or SGLT1 (right) and their variants under conditions with or without cholesteryl hemisuccinate (CHS) (mean ± SEM; n=3 biological replicates). e, The transport of αMDG by SGLT1 WT (left) and SGLT1conHA (right) in the presence of various concentrations of αMDG. Data were plotted according to the equation, U=Umax x [S]/ (K0.5+[S]) (mean ± SEM; n=3 biological replicates).
Extended Data Fig. 4 Cryo-EM sample preparation and data processing of SGLT1.
a, The elution profile of SGLT1con-Nb1 on a size-exclusion column. The insert shows SDS-PAGE analysis of the purified sample. Data are representative of five independent experiments with similar results. b, Representative cryo-EM micrograph of SGLT1con-Nb1 complex particles (from 15,039 micrographs with similar results). c, Selected 2D class averages of SGLT1con-Nb1 complex (from 100 classes with similar results). d, e, The workflow of classification and refinement. The overall nominal resolutions of the SGLT1con-Nb1 complex and the SGLT1conHA-Nb1 complex were determined by the ‘gold standard’ FSC curve using the FSC=0.143 criterion. f, Overlay of the SGLT1con model with the density map of SGLT1conHA.
Extended Data Fig. 5 Cryo-EM densities and refined models.
a, Local resolution of the cryo-EM map of the SGLT1conHA-Nb1 complex. b, Cryo-EM densities and model of SGLT1conHA transmembrane helices and extracellular loops. c, Local resolution of the cryo-EM map of the SGLT1con-Nb1 complex. d, Cryo-EM densities and model of SGLT1con transmembrane helices. e, Local resolution of the cryo-EM map of the SMCT1-Nb2 complex. f, Cryo-EM densities and model of SMCT1 transmembrane helices.
Extended Data Fig. 6 Functional characterization, cryo-EM sample preparation, and data processing of SMCT1.
a, Time course of pyruvate uptake by SMCT1 expressing oocytes (mean ± SEM; n=3 biological replicates). b, The transport of pyruvate by SMCT1 in the presence of various concentrations of pyruvate (mean ± SEM; n=3 biological replicates). c, The size-exclusion chromatography of SMCT1-Nb2 complex and SDS-PAGE analysis of the purified sample. Data are representative of five independent experiments with similar results. d, Representative cryo-EM micrograph of the SMCT1-Nb2 complex (from 8,823 micrographs with similar results). e, Selected 2D class averages of SMCT1-Nb2 complex particles (from 100 classes with similar results). f, The workflow of data processing on the SMCT1-Nb2 complex. The overall nominal resolutions of the SMCT1-Nb2 complex were determined by the ‘gold standard’ FSC curve using the FSC=0.143 criterion.
Extended Data Fig. 7 Structural features of SGLT1 and substrate selectivity.
a, The density map of the cholesteryl hemisuccinate binding site of SGLT1conHA. The cholesteryl hemisuccinate density map is indicated by dashed red oval. b, Structural overlay of SGLT1conHA (orange) and a dopamine transporter DAT (cyan, PDB: 4M48). The helices near the cholesterol binding site are shown as ribbons. c, The overall organization of the lid domain of SGLT1con. Disulfide bonds are indicated by dashed blue circles. d, Close view of the four disulfide bonds. e, For five simulations of cholesterol-bound SGLT1con, the heavy atom RMSD of cholesterol from its initial position is plotted over time. f, Conservation surface mapping of SGLT1. The conservation scores are calculated from 200 SGLT1 sequences using ConSurf. The cytosolic vestibule (middle) and extracellular cavity (right) are indicated by dashed yellow oval. g, Uptake activities of SGLT1 T287A variant (mean ± SEM; n=3 biological replicates. WT and control are the same as in Fig. 2c). h, αMDG (left) and galactose (right) uptake activities of SGLT1 variants with point mutations in the substrate binding pocket on residues that are different between SGLT1 and vSGLT (mean ± SEM; n=3 biological replicates).
Extended Data Fig. 8 Sodium-binding sites and SMCT1’s substrate binding site.
a, Structural overlay of SGLT1conHA (orange), SMCT1 (cyan), and SiaT (gray, PDB: 5NV9). The helices involved in sodium binding are shown as ribbons. The shift of TM helices from SiaT to SGLT1conHA or SMCT1-butyrate is depicted by red arrows. b, Sodium-binding sites compared between SGLT1conHA (yellow) or SMCT1 (yellow) and SiaT (gray). Residues in Na2 or Na3 sites are shown as sticks. c, Uptake activities of SGLT1 with mutations in the Na3-binding site. Uptake activities are normalized to WT (mean ± SEM; n=4 biological replicates). d, SMCT1-butyrate interaction shown as Ligplot+ diagram (yellow dashed lines, hydrogen bonds; spokes, hydrophobic interactions). e, Pyruvate uptake activities of SMCT1 mutants compared to WT (mean ± SEM; n=3 biological replicates).
Extended Data Fig. 9 Structural comparison among members of SSS family.
a, Superposition of the binding pockets of SMCT1 and apo SGLT1conHA. Transmembrane helices involved in forming the central pockets are labeled. The relative positions of substrates are indicated by 3D shapes: pink hexagon for glucose and orange oval for butyrate. SMCT1 and SGLT1conHA are colored in cyan and gray, respectively. b, Surface representation of the central cavity of SMCT1 (left) and SGLT1conHA (right). Substrates are placed in the binding sites, the extension of which is indicated by dashed yellow ovals. c, The sequence comparison of the substrate binding site residues. For the sugar-transporting branch, the positions equivalent to SGLT1’s sugar binding site residues are highlighted in orange. For the metabolite-transporting branch, the positions equivalent to SMCT1’s substrate binding site residues are highlighted in blue. d, Sliced view of SGLT1conHA (left panel) and SMCT1-butyrate (right panel). e, The superimposed SGLT1 (inward-facing) and SiaT (outward-facing). Zoomed-in view of regions that undergo considerable conformational changes are shown in blue boxes on the right (unrelated helices or loops are removed for clarity). The shift of TM helices between SiaT (gray) and SGLT1 (orange) is indicated by black arrows. From outward-open to inward-facing conformation, the N-terminal half of TM10 undergoes significant inward movement around a Gly-Pro-Pro motif at the center of the helix. Concomitantly, the short loop connecting TM9-TM10 and the C-terminal part of TM9 also moves inward. As a result, the N-terminal end of TM10 and the TM9-TM10 loop come into contact with TM2 and EL4 of the extracellular domain, which collapses the extracellular vestibule and stabilizes the closed conformation of the extracellular gate. Phe453TM10, at the end of TM10, thus moves into a position to contact other extracellular gate residues to shield the substrate-binding pocket from the extracellular solution. In association, TM11 and TM12 tilt away to accommodate the movement of TM10. On the intracellular side, TM5, together with TM4, tilts outward while TM8 and TM9 tilt away from TM1, TM5 and TM6. These movements open the intracellular entrance of the vestibule and widen the permeation pathway to enable substrate release. The increased distance between TM8 and TM1/TM5 is linked with the disruption of both Na2 and Na3 sites. Thus, Na+ binding is coupled to the conformational changes during state transitions and glucose transport. During state transitions, the extracellular lid domain is also expected to undergo significant conformational changes, which might help stabilize conformational states or give rise to distinct surface features to modulate Na+ transport. f, Structural comparison of SGLT1conHA (orange), SMCT1 (cyan) and vSGLT (gray, PDB: 3DH4). g, Structural comparison of SGLT1conHA (orange), SMCT1 (cyan). The orientation difference of the extracellular domain is zoomed-in in red box.
Extended Data Fig. 10 Substrate binding and water permeation of SGLT1.
a, For five simulations of SGLT1con with glucose and two sodium ions initially placed in the glucose and sodium binding sites, the backbone RMSD of SGLT1con from the cryo-EM structure is plotted over time. b, For five simulations of SGLT1con with glucose and two sodium ions initially placed in the glucose and sodium binding sites, the heavy atom RMSD of glucose from its initial position is plotted over time. c, A frame from every 200 ns of the 2 μs molecular dynamics simulation (simulation no. 1 in panels (a, b)) shows the position of glucose in the binding pocket (red at t = 0, transitioning to yellow at t = 2 μs). d, Hydrogen bonds between glucose and SGLT1con binding pocket residues are shown in black lines for simulation no. 1 in panels (a, b). e, Hydrogen bonds between glucose and the SGLT1con binding pocket residues are shown as the percentage of total simulation time for all simulations in panels (a, b). f, Water occupancy averaged over time for glucose-bound SGLT1con simulation no. 1 in panels (a, b) (left), and for a 4 μs apo SGLT1con simulation (right). Water density is shown in dark blue mesh (contoured at 0.0334 water molecules/Å3, approximately the bulk density), and glucose is shown in yellow sticks. g, The backbone RMSD of SGLT1con from the cryo-EM structure (left), and the heavy atom RMSD of glucose from its initial position (right) for five simulations of SGLT1con with glucose initially placed in the glucose binding site and with no sodium initially placed in the sodium binding sites. Sodium did not enter the sodium binding sites during the timescale of these simulations. h, Uptake activities of SGLT1 mutants. Oocyte-based urea uptake activities with or without inhibitor (200 µM phlorizin, Pz) are compared to the wild-type (WT) transporter (mean ± SEM; n=3 biological replicates). i, Time course of urea uptake by SGLT1 WT and mutants with or without inhibitor phlorizin (Pz). Uptake data were plotted using linear regression (mean ± SEM; n=3 biological replicates).
Supplementary information
Rights and permissions
About this article
Cite this article
Han, L., Qu, Q., Aydin, D. et al. Structure and mechanism of the SGLT family of glucose transporters. Nature 601, 274–279 (2022). https://doi.org/10.1038/s41586-021-04211-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-021-04211-w
This article is cited by
-
Integrated mRNA and miRNA analysis reveals the regulatory network of oxidative stress and inflammation in Coilia nasus brains during air exposure and salinity mitigation
BMC Genomics (2024)
-
Ion and lipid orchestration of secondary active transport
Nature (2024)
-
Transport and inhibition mechanism for VMAT2-mediated synaptic vesicle loading of monoamines
Cell Research (2024)
-
Future opportunities in solute carrier structural biology
Nature Structural & Molecular Biology (2024)
-
Transport and inhibition mechanism of the human SGLT2–MAP17 glucose transporter
Nature Structural & Molecular Biology (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.